Carles Roca
Bellaterra, CT 08193, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
AAV-mediated FGF21 gene therapy promotes health span extension by whole-body tissue-specific adaptations.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 11, 2025
Oral Presentation Award Winner: LDL-C Reduction in Diabetic Patients after Percutaneous Coronary Intervention: Is There any Difference with Non-diabetic?
Journal: European cardiology
Published: July 05, 2023
Prospective associations between a priori dietary patterns adherence and kidney function in an elderly Mediterranean population at high cardiovascular risk.
Journal: European journal of nutrition
Published: August 10, 2021
Seven-year follow-up of durability and safety of AAV CNS gene therapy for a lysosomal storage disorder in a large animal.
Journal: Molecular therapy. Methods & clinical development
Published: March 16, 2021
Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID.
Journal: Human molecular genetics
Published: December 02, 2016
AAV-mediated Sirt1 overexpression in skeletal muscle activates oxidative capacity but does not prevent insulin resistance.
Journal: Molecular therapy. Methods & clinical development
Published: July 29, 2016
Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC.
Journal: Disease models & mechanisms
Published: February 24, 2016
ALOX5AP Overexpression in Adipose Tissue Leads to LXA4 Production and Protection Against Diet-Induced Obesity and Insulin Resistance.
Journal: Diabetes
Published: January 08, 2016
AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease.
Journal: Molecular therapy. Methods & clinical development
Published: January 01, 2014
Last Updated: 09/26/2026